3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: triapine|DRUG: gemcitabine hydrochloride|OTHER: laboratory biomarker analysis|OTHER: pharmacological study
Sponsor: National Cancer Institute (NCI)